ERBB2 and breast carcinoma: Consensus at global and national levels is urgently needed in this setting as a framework for analytical (technical) and post-analytical (interpretative) training.42 The implementation of new methodology should be based on GC data but take into serious consideration the previous vicissitudes in the experience of breast cancer HER2 testing.43